All News

Thirty-five projects covered by the funding will help build infrastructure and assist industry in adapting processes to use this form of energy

Research infrastructures are worried about the rising cost of running large scientific experiments and are looking for help with paying sky-high electricity bills. One lab has seen a 60% increase in its tariff this year

At a Science|Business conference Sept. 7, global science leaders debated whether and how to deal with Russia. Watch the highlights video, and take the survey

In the name of competition, the European Commission wants to stop the US DNA sequencing company from buying a US leader in applying DNA sequencing to novel cancer diagnostics. The view from the ground in Europe is that it may not matter so much

With fertiliser shortages, drought and declining soil fertility threatening agricultural production in Europe, there is increased pressure to relax EU rules on the use of genome editing in plant breeding

It can provide answers, but science alone will not deliver on sustainable development goals, says Maria Leptin in a reality check on ‘scientific populism’

Financing is part of a financing portfolio worth over €15B to encourage companies to invest in climate change-related technologies and end Europe’s dependence on imports of fossil fuel from Russia

European policy encourages researchers to move freely between borders, but blanket EU labour rules are getting in the way. With pandemic travel restrictions lifted the administration costs are giving institutions a headache

As elections near, Biden promotes ‘whole-of-government’ effort to cut cancer death rates and strengthen the biopharma and biotech sectors. International partners welcome, up to a point

The EU succeeded in creating a portfolio of vaccines and procuring enough doses to go round, but contracts did not make provisions for disruptions to supplies

The country’s record on academic freedom is far from stellar, but the hope is these partnerships will help bolster commitment to researcher autonomy

Setting a separate target for deployment of novel renewable technologies could open up markets for start-ups, but there are also other barriers that need to be lifted

Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

At last Wednesday’s annual conference, Science|Business launched a brand-new media service focusing on the research and innovation divide in Europe.

In case you missed the first edition of the accompanying newsletter, you can find it here and sign-up for future editions.